A Win For Trevena, Inc.
Mon 10 Aug 20 at 05:34 PM
Trevena, Inc. (TRVN:NASDAQ) jumped higher at $3.13, a gain of 31.5%. On Fri 07 Aug 20, TRVN:NASDAQ touched a New 2-Week Intraday Low of $1.72. The stock appeared on our News Catalysts scanner on Mon 10 Aug 20 at 07:02 AM in the 'BIOTECH' category. From Fri 24 Jul 20, the stock recorded 40.00% Up Days and 54.55% Green Days
The stock spiked on Tue 04 Aug 20 at $3.47 with a volume of 32M+.
About Trevena, Inc. (TRVN:NASDAQ)
Trevena Inc is a clinical stage biopharmaceutical company. It discovers, develops and commercialize therapeutics that use a novel approach to target G protein coupled receptors.
Top 10 Gainers:
- Seres Therapeutics, Inc. (MCRB:NASDAQ), 389.22%
- Omeros Corporation (OMER:NASDAQ), 50.88%
- BiomX Inc. (PHGE:NYSEMKT), 42.1%
- Commercial Vehicle Group, Inc. (CVGI:NASDAQ), 37.04%
- Xtant Medical Holdings, Inc. (XTNT:NYSEMKT), 32.43%
- Adamas Pharmaceuticals, Inc. (ADMS:NASDAQ), 31.75%
- Trevena, Inc. (TRVN:NASDAQ), 31.51%
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 30.51%
- LSB Industries, Inc. (LXU:NYSE), 29.75%
- Ocugen, Inc. (OCGN:NASDAQ), 28.18%